Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CAFERGOT TAB DIN 00176095

Status: Cancelled Post Market
Holder: NOVARTIS PHARMACEUTICALS CANADA INC
Molecule: ERGOTAMINE TARTRATE

Health Canada record

Active ingredient(s)ERGOTAMINE TARTRATE 1 MG; CAFFEINE 100 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCN02CA52 ERGOTAMINE, COMBINATIONS EXCL. PSYCHOLEPTICS
Original market date31-Dec-1951
Current status date31-Mar-2014
SourceHealth Canada DPD

Establishment licence of the holder

Novartis Pharmaceuticals Canada Inc — licence 100273, currently licensed, last inspection rating C (2025-01-14).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ERGOTAMINE TARTRATE

DINProductCompanyFormStrengthStatus
00782920CAFERGOT SUPNOVARTIS PHARMACEUTICALS CANADA INCSuppositoryERGOTAMINE TARTRATE 2 MG; CAFFEINE 100 MGCancelled Post Market
00156086ERGODRYL CAPERFA CANADA 2012 INCCapsuleERGOTAMINE TARTRATE 1 MG; CAFFEINE CITRATE 100 MG; DIPHENHYDRAMINE HYDROCHLORIDE 25 MGCancelled Post Market
00328952ERGOMAR SLT 2MGAVENTIS PHARMA INCTabletERGOTAMINE TARTRATE 2 MGCancelled Post Market
00116858GRAVERGOL CAPSULESCAN-MED PHARMA INC.CapsuleERGOTAMINE TARTRATE 1 MG; CAFFEINE 100 MG; DIMENHYDRINATE 50 MGCancelled Post Market
00068586MEGRAL TABSGLAXO WELLCOME INC.TabletERGOTAMINE TARTRATE 2 MG; CYCLIZINE HYDROCHLORIDE 50 MG; CAFFEINE 100 MGCancelled Post Market
00489212WIGRAINE SUPPOSITORIESORGANON CANADA LTD LTEESuppositoryERGOTAMINE TARTRATE 1 MG; CAFFEINE 100 MG; BELLADONNA .1 MGCancelled Post Market
00489220WIGRAINE TABORGANON CANADA LTD LTEETabletERGOTAMINE TARTRATE 1 MG; CAFFEINE 100 MG; BELLADONNA .1 MGCancelled Post Market

International API supply for ERGOTAMINE TARTRATE

2 valid EDQM Certificates of Suitability from 2 holders. 2 active FDA Drug Master Files.

Request a quote for CAFERGOT TAB

How to read a Canadian DIN record